View Older Stories View More Recent Stories

Mar 27, 2026 05:12AM Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'

Mar 26, 2026 01:17PM BofA on Hims and Hers (HIMS): '$149/month subscription fee is slightly higher than we initially expected'

Mar 26, 2026 12:00PM HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications

Mar 18, 2026 08:55AM HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk

Mar 16, 2026 06:16AM Street Calls of the Week

Mar 13, 2026 10:09AM Hims shares set for best week on record after new Novo Nordisk deal

Mar 10, 2026 08:10PM Hims & Hers hires ex-Eli Lilly PR chief Beiser as top communications officer

Mar 10, 2026 06:10AM BofA Securities Upgrades Hims and Hers (HIMS) to Neutral

Mar 10, 2026 05:10AM Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)

Mar 9, 2026 04:10PM Citi Upgrades Hims and Hers (HIMS) to Neutral

Mar 9, 2026 02:53PM Hims & Hers Health, Inc. (HIMS) call put ratio 2.2 calls to 1 put as share price up 41%

Mar 9, 2026 12:23PM TD Cowen: 'Wegovy Injection may be declining'

Mar 9, 2026 11:24AM Needham Upgrades Hims and Hers (HIMS) to Buy

Mar 9, 2026 11:08AM Nephron Upgrades Hims and Hers (HIMS) to Buy

Mar 9, 2026 10:15AM BTIG Reiterates Neutral Rating on Hims and Hers (HIMS) following Novo partnership

Mar 9, 2026 08:58AM Truist Reiterates Hold Rating on Hims and Hers (HIMS)

Mar 9, 2026 08:46AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS) amid Novo partnership

Mar 9, 2026 08:30AM HIMS partners with Novo Nordisk, shifts US weight loss strategy

Mar 9, 2026 06:53AM Hims soars 44% on report Novo Nordisk to sell weight-loss drugs on its platform

Mar 3, 2026 04:02PM FDA issues 30 warning letters to telehealth firms over GLP-1 claims

Mar 3, 2026 10:02AM Prior to Market Open: Endpoint News Reports 'HIMS’ pharmacy partner will reintroduce GLP-1 pill pulled from market'

Feb 24, 2026 11:51AM Jefferies: 'We appreciate and agree with what HIMS mgmt is doing'

Feb 24, 2026 09:39AM Hims and Hers (HIMS) PT Lowered to $18 at Truist Securities

Feb 24, 2026 09:16AM Hims and Hers (HIMS) PT Lowered to $17 at TD Cowen Amid NT Uncertainty

Feb 24, 2026 08:33AM KeyBanc Reiterates Sector Weight Rating on Hims and Hers (HIMS)

Feb 24, 2026 07:51AM BTIG Downgrades Hims and Hers (HIMS) to Neutral

Feb 24, 2026 06:27AM Hims and Hers (HIMS) PT Lowered to $17.50 at Leerink Partners

Feb 24, 2026 05:27AM Hims and Hers (HIMS) PT Lowered to $24 at Evercore ISI

Feb 24, 2026 05:11AM Hims and Hers (HIMS) PT Lowered to $12.50 at BofA Securities

Feb 23, 2026 04:42PM After-hours movers: Hims & Hers Health, Keysight, Bed Bath & Beyond, Myriad Genetics, and more

Feb 23, 2026 04:07PM Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 3c, Offers Guidance

Feb 23, 2026 12:00PM Hims & Hers is due to report after the bell. Here's what to watch out for.

Feb 23, 2026 04:00AM Hims & Hers Health Inc. set to report Q4 earnings with guidance cut fears mounting after compounded semaglutide fallout

Feb 22, 2026 03:00PM Hims & Hers Health (HIMS) stock: Should you buy the dip after massive selloff?

Feb 10, 2026 06:01AM Hims and Hers (HIMS) PT Lowered to $30 at Canaccord Genuity

Feb 9, 2026 12:13PM Hims and Hers (HIMS) PT Lowered to $13 at BofA Securities

Feb 9, 2026 08:26AM Hims and Hers (HIMS) PT Lowered to $20 at Leerink Partners

Feb 9, 2026 07:14AM Needham Reiterates Hold Rating on Hims and Hers (HIMS)

Feb 9, 2026 07:00AM Novo Nordisk sues Hims & Hers over compounded semaglutide products

Feb 9, 2026 06:53AM Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill

Feb 9, 2026 06:41AM BTIG Reiterates Buy Rating on Hims and Hers (HIMS)

Feb 9, 2026 05:56AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.2 calls to 1 put into stopping offering access to semaglutide pill

Feb 9, 2026 05:52AM Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS)

Feb 9, 2026 05:37AM Hims and Hers (HIMS) PT Lowered to $21 at BofA Securities

Feb 9, 2026 04:45AM Hims & Hers Health (HIMS) said to stop offering weight loss pill

Feb 6, 2026 04:51PM FDA moves to restrict copycat GLP-1 weight loss drugs

Feb 6, 2026 07:58AM Hims & Hers stock falls after FDA warns against illegal copycat drugs

Feb 6, 2026 06:04AM TD Cowen Reiterates Hold Rating on Hims and Hers (HIMS)

Feb 5, 2026 12:35PM Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'

Feb 5, 2026 10:46AM Novo Nordisk threatens legal action over Hims & Hers semaglutide pill

View More Recent Stories View Older Stories